CellaVision AB Statistics

Total Valuation

CellaVision AB has a market cap or net worth of SEK 6.28 billion. The enterprise value is 6.21 billion.

Market Cap	6.28B
Enterprise Value	6.21B

Important Dates

The next estimated earnings date is Thursday, October 24, 2024.

Earnings Date	Oct 24, 2024
Ex-Dividend Date	May 6, 2024

Share Statistics

CellaVision AB has 23.85 million shares outstanding.

Shares Outstanding	23.85M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	6.90%
Owned by Institutions (%)	60.05%
Float	19.81M

Valuation Ratios

The trailing PE ratio is 43.33 and the forward PE ratio is 34.14. CellaVision AB's PEG ratio is 2.04.

PE Ratio	43.33
Forward PE	34.14
PS Ratio	8.65
PB Ratio	8.50
P/FCF Ratio	26.05
PEG Ratio	2.04

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 28.50, with an EV/FCF ratio of 25.73.

EV / Earnings	42.79
EV / Sales	8.55
EV / EBITDA	28.50
EV / EBIT	33.78
EV / FCF	25.73

Financial Position

The company has a current ratio of 2.92, with a Debt / Equity ratio of 6.08.

Current Ratio	2.92
Quick Ratio	1.99
Debt / Equity	6.08
Debt / EBITDA	0.21
Debt / FCF	0.19
Interest Coverage	71.33

Financial Efficiency

Return on equity (ROE) is 20.74% and return on invested capital (ROIC) is 15.00%.

Return on Equity (ROE)	20.74%
Return on Assets (ROA)	12.38%
Return on Capital (ROIC)	15.00%
Revenue Per Employee	3.29M
Profits Per Employee	656,385
Employee Count	221
Asset Turnover	0.78
Inventory Turnover	1.76

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +38.83% in the last 52 weeks. The beta is 1.12, so CellaVision AB's price volatility has been higher than the market average.

Beta (5Y)	1.12
52-Week Price Change	+38.83%
50-Day Moving Average	255.92
200-Day Moving Average	231.23
Relative Strength Index (RSI)	54.76
Average Volume (20 Days)	15,253

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, CellaVision AB had revenue of SEK 726.40 million and earned 145.06 million in profits. Earnings per share was 6.08.

Revenue	726.40M
Gross Profit	483.96M
Operating Income	183.76M
Pretax Income	181.98M
Net Income	145.06M
EBITDA	205.85M
EBIT	183.76M
Earnings Per Share (EPS)	6.08

Full Income Statement

Balance Sheet

The company has 122.26 million in cash and 44.98 million in debt, giving a net cash position of 77.28 million or 3.24 per share.

Cash & Cash Equivalents	122.26M
Total Debt	44.98M
Net Cash	77.28M
Net Cash Per Share	3.24
Equity (Book Value)	739.33M
Book Value Per Share	31.00
Working Capital	244.21M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 260.99 million and capital expenditures -19.74 million, giving a free cash flow of 241.25 million.

Operating Cash Flow	260.99M
Capital Expenditures	-19.74M
Free Cash Flow	241.25M
FCF Per Share	10.11

Full Cash Flow Statement

Margins

Gross margin is 66.62%, with operating and profit margins of 25.30% and 19.97%.

Gross Margin	66.62%
Operating Margin	25.30%
Pretax Margin	25.05%
Profit Margin	19.97%
EBITDA Margin	28.34%
EBIT Margin	25.30%
FCF Margin	33.21%

Dividends & Yields

This stock pays an annual dividend of 2.25, which amounts to a dividend yield of 0.85%.

Dividend Per Share	2.25
Dividend Yield	0.85%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	2
Payout Ratio	37.00%
Buyback Yield	n/a
Shareholder Yield	0.85%
Earnings Yield	2.31%
FCF Yield	3.84%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a